Medtronic SG&A decreased by 0.3% to $2.96B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.8%, from $2.72B to $2.96B. Over 4 years (FY 2021 to FY 2025), SG&A shows relatively stable performance with a 1.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Detailed definition
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Peer comparison
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
selling_general_and_administrativeHistorical Data
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.60B | $2.55B | $2.62B | $2.56B | $2.57B | $2.57B | $2.62B | $2.62B | $2.62B | $2.61B | $2.69B | $2.67B | $2.77B | $2.66B | $2.76B | $2.72B | $2.72B | $2.81B | $2.97B | $2.96B |
| QoQ Change | — | -1.8% | +2.7% | -2.1% | +0.3% | -0.1% | +1.9% | -0.1% | +0.0% | -0.1% | +2.8% | -0.5% | +3.4% | -4.0% | +3.8% | -1.5% | +0.1% | +3.2% | +5.7% | -0.3% |
| YoY Change | — | — | — | — | -1.0% | +0.8% | +0.1% | +2.1% | +1.8% | +1.8% | +2.6% | +2.2% | +5.7% | +1.6% | +2.6% | +1.6% | -1.6% | +5.7% | +7.5% | +8.8% |
Product Breakdown
| Segment | FY'23 | FY'24 | FY'25 |
|---|---|---|---|
| Shipping and Handling | $351.00M | $341.00M | $322.00M |
| Total | $10.42B | $10.74B | $10.85B |
All segment values are derived from annual filings.
SG&A at Other Companies
Frequently Asked Questions
- What is Medtronic's sg&a?
- Medtronic (MDT) reported sg&a of $2.96B in Q4 2025.
- How has Medtronic's sg&a changed year-over-year?
- Medtronic's sg&a increased by 8.8% year-over-year, from $2.72B to $2.96B.
- What is the long-term trend for Medtronic's sg&a?
- Over 4 years (2021 to 2025), Medtronic's sg&a has grown at a 1.7% compound annual growth rate (CAGR), from $10.15B to $10.85B.
- What does sg&a mean?
- The overhead costs of running the business, including sales, marketing, and general corporate expenses.